THERAPEUTIC AGENTS FOR OCULAR INFLAMMATORY DISEASE COMPRISING INTERLEUKIN 6 RECEPTOR INHIBITOR AS ACTIVE INGREDIENT
Long-Term Treatment With Interleukin-6 Receptor Inhibitor Tocilizumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease
REMEDY FOR GRAFT-VERSUS-HOST DISEASE COMPRISING INTERLEUKIN-6 RECEPTOR INHIBITOR AS THE ACTIVE INGREDIENT
Expression inhibitor comprising an antisense oligonucleotide derivative corresponding to human interleukin-6 receptor
EXPRESSION INHIBITOR CONTAINING ANTISENSE OLIGONUCLEOTIDE DERIVATIVE AGAINST HUMAN INTERLEUKIN-6 RECEPTOR
